Market Price Volatility Risk on Investment Securities
First written in FY2017. 5 of 13 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2026.
Umios moved to the "Worse" side of this theme in 2020, 1 year after the typical company in this theme (2019).
The whole theme swung hardest in 2019: 54 of 136 companies on the "Worse" side.
39 other companies' latest entry also says "Other".
- FY2026Continued sale of cross-shareholdings and recognition of valuation lossesAnnual report
「During the fiscal year, in accordance with this policy, the Board of Directors reviewed whether individual issues should continue to be held at its meeting on 5 August 2025 and sold some of the cross-shareholdings.」
12 issues, including cross-shareholdings, were sold, resulting in proceeds of ¥10,889 million and a gain on sale of ¥7,717 million. At the same time, an impairment loss of ¥146 million on investment securities was recognized, and the risk from market price fluctuations remains. - FY2025MitigatedAnnual report
「During the fiscal year, in accordance with this policy, the Board of Directors reviewed whether individual issues should continue to be held at its meeting on 24 September 2024 and sold some of the cross-shareholdings.」
Investment securities, including 17 cross-shareholdings, were sold, resulting in proceeds of ¥15,675 million and a gain on sale of ¥10,903 million. Holdings are being reduced after reviewing their strategic significance. - FY2025-H1Recognition of Gain on Sale of Investment SecuritiesAnnual report
「Gain on sale of investment securities: ¥7,111 million」
A gain of ¥7,111 million on the sale of investment securities was recognized. The risk of fluctuations in investment securities' market prices has materialized as an impact on earnings from the sales. - FY2024-Q3WorsenedAnnual report
「Valuation loss on investment securities: 343」
A ¥343 million valuation loss on investment securities was recognized, up from ¥206 million in the same period of the previous year. Losses attributable to market price fluctuations and other factors have expanded. - FY2024-Q2WorsenedAnnual report
「Valuation loss on investment securities: 421」
A ¥421 million valuation loss on investment securities was recognized, up from ¥210 million in the same period of the previous year. Losses attributable to market price fluctuations and other factors have expanded. - FY2024-Q1WorsenedAnnual report
「Valuation loss on investment securities: 365」
The valuation loss on investment securities increased from ¥272 million in the same period of the previous year to ¥365 million, and losses attributable to risks such as market price fluctuations expanded. - FY2023MaterialisedAnnual report
「During the consolidated fiscal year, impairment losses of ¥199 million were recognized on securities, comprising ¥196 million on shares other than shares, etc. without market prices, classified as other securities, and ¥3 million on shares, etc. without market prices, classified as other securities.」
Risks related to investment securities' market prices or the financial condition of issuers materialized as ¥199 million in impairment losses. - FY2023-Q1MaterialisedAnnual report
「Valuation loss on investment securities: ¥272 million」
Risks related to investment securities' market prices or the financial condition of issuers materialized as ¥272 million in valuation losses. - FY2022MaterialisedAnnual report
「During the consolidated fiscal year, impairment losses of ¥78 million were recognized on securities, comprising ¥0 million on listed shares classified as other securities, ¥8 million on unlisted shares classified as other securities, and ¥69 million on shares of affiliated companies.」
Risks related to declines in the value of investment securities and the financial condition of issuers materialized as ¥78 million in impairment losses. - FY2021MaterialisedAnnual report
「During the consolidated fiscal year, impairment losses of ¥360 million were recognized on securities, comprising ¥27 million on listed shares classified as other securities and ¥332 million on unlisted shares classified as other securities.」
Risks related to investment securities' market prices and the financial condition of issuers materialized as ¥360 million in impairment losses. - FY2021-Q1MaterialisedAnnual report
「Impairment loss on investment securities ¥255 million」
A ¥255 million valuation loss on investment securities was recognized, demonstrating that the risk of market price fluctuations had materialized as a valuation loss. - FY2018RestatedAnnual report
「Investment securities consist mainly of shares related to business or capital alliances, and are exposed to the risk of fluctuations in market prices.」
The Company continues to disclose the risk of fluctuations in the market prices of investment securities. - FY2017First statedAnnual report
「Investment securities consist mainly of bonds held to maturity and shares related to business or capital alliances, and are exposed to the risk of fluctuations in market prices.」
The risk of market price fluctuations for investment securities, including bonds and shares, is disclosed.